Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention

Molecular Nutrition and Food Research

Volumn 58, Issue 10, 2014, Pages 2001-2013

[No Author Info available]

Author keywords

Chemoprevention; Prostate cancer; RNA sequencing; Specificity protein 1; Sulforaphane

Indexed keywords

ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SMALL INTERFERING RNA; SP1 PROTEIN, HUMAN; SULFORAFAN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTOME; TUMOR PROTEIN;

ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; CARCINOGENESIS; CELL CULTURE; CHEMOPROPHYLAXIS; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; PROSTATE; PROSTATIC NEOPLASMS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; CARCINOGENESIS; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOPREVENTION; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; ISOTHIOCYANATES; MALE; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTOME;

EID: 84908428951     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400269     Document Type: Article

References (46)

1. International Agency for Research on Cancer, GLOBOCAN, Cancer Fact Sheet: Prostate Cancer, 2010.
2. American Cancer Society, Cancer Facts & Figures 2012. Atlanta:American Cancer Society Press, 2012.
3. Liu, B., Mao, Q., Cao, M., Xie, L., Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int. J. Urol. 2012, 19, 134-141.
4. Higdon, J. V., Delage, B., Williams, D. E., Dashwood, R. H., Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 2007, 55, 224-236.
5. Singh, S. V., Warin, R., Xiao, D., Powolny, A. A. et al., Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2009, 69, 2117-2125.
6. Agyeman, A. S., Chaerkady, R., Shaw, P. G., Davidson, N. E. et al., Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat. 2012, 132, 175-187.
7. Bhamre, S., Sahoo, D., Tibshirani, R., Dill, D. L. et al., Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate 2009, 69, 181-190.
8. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W. et al., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotidemicroarray. Cancer Res. 2002, 62, 5196-5203.
9. Hu, R., Xu, C., Shen, G., Jain, M. R. et al., Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett. 2006, 243, 170-192.
10. Clarke, J. D., Hsu, A., Yu, Z., Dashwood, R. H. et al., Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol. Nutr. Food Res. 2011, 55, 999-1009.
11. Hsu, A., Wong, C. P., Yu, Z., Williams, D. E. et al., Promoter demethylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin. Epigenetics 2011, 3, 3.
12. Ho, E., Clarke, J. D., Dashwood, R. H., Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009, 139, 2393-2396.
13. Hu, R., Hebbar, V., Kim, B. R., Chen, C. et al., In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther. 2004, 310, 263-271.
14. Khor, T. O., Hu, R., Shen, G., Jeong, W. S. et al., Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm. Drug. Dispos. 2006, 27, 407-420.
15. Gross-Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K. et al., Sulforaphane- and phenethyl isothiocyanateinduced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol. Sci. 2010, 116, 422-432.
16. Costa, V., Angelini, C., De Feis, I., Ciccodicola, A., Uncovering the complexity of transcriptomes with RNA-Seq. J. Biomed. Biotechnol. 2010, 2010, 853916.
17. Cumbie, J. S., Kimbrel, J. A., Di, Y., Schafer, D. W. et al., GENE-counter: a computational pipeline for the analysis of RNA-Seq data for gene expression differences. PLoS One 2011, 6, e25279.
18. Pflueger, D., Terry, S., Sboner, A., Habegger, L. et al., Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2011, 21, 56-67.
19. Maher, C. A., Kumar-Sinha, C., Cao, X., Kalyana-Sundaram, S. et al., Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458, 97-101.
20. Clarke, J. D., Hsu, A., Williams, D. E., Dashwood, R. H. et al., Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res. 2011, 28, 3171-3179.
21. Myzak, M. C., Hardin, K., Wang, R., Dashwood, R. H. et al., Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006, 27, 811-819.
22. Myzak, M. C., Karplus, P. A., Chung, F. L., Dashwood, R. H., A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer. Res. 2004, 64, 5767-5774.
23. Trapnell, C., Roberts, A., Goff, L., Pertea, G. et al., Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7, 562-578.
24. Beaver, L.M., Yu, T.W., Sokolowski, E. I., Williams, D. E. et al., 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol. Appl. Pharmacol. 2012, 263, 345-351.
25. Hunter, J. D., Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 2007, 9, 90-95.
26. Hulsen, T., de Vlieg, J., Alkema, W., BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008, 9, 488.
27. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
28. Meyer, L. R., Zweig, A. S., Hinrichs, A. S., Karolchik, D. et al., The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 2013, 41, D64-D69.
29. Matys, V., Kel-Margoulis, O. V., Fricke, E., Liebich, I. et al., TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006, 34, D108-D110.
30. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C. et al., Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921.
31. Wong, C. P., Bray, T. M., Ho, E., Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett. 2009, 276, 38-46.
32. Sankpal, U. T., Goodison, S., Abdelrahim, M., Basha, R., Targeting Sp1 transcription factors in prostate cancer therapy. Med. Chem. 2011, 7, 518-525.
33. Chambers, K. F., Bacon, J. R., Kemsley, E. K., Mills, R. D. et al., Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure. Prostate 2009, 69, 1411-1421.
34. Traka, M. H., Spinks, C. A., Doleman, J. F., Melchini, A. et al., The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer. Mol. Cancer 2010, 9, 189.
35. Melchini, A., Needs, P. W., Mithen, R. F., Traka, M. H., Enhanced in vitro biological activity of synthetic 2-(2-pyridyl) ethyl isothiocyanate compared to natural 4-(methylsulfinyl) butyl isothiocyanate. J. Med. Chem. 2012, 55, 9682-9692.
36. Li, L., Davie, J. R., The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat. 2010, 192, 275-283.
37. Bedolla, R. G., Gong, J., Prihoda, T. J., Yeh, I. T. et al., Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. PLoS One 2012, 7, e44917.
38. Lu, S., Archer, M. C., Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int. J. Cancer 2010, 126, 416-425.
39. Chew, Y. C., Adhikary, G., Wilson, G. M., Xu, W. et al., Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent. J. Biol. Chem. 2012, 287, 16168-16178.
40. Ren, F., Zhang, S., Mitchell, S. H., Butler, R. et al., Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 2000, 19, 1924-1932.
41. Chintharlapalli, S., Papineni, S., Ramaiah, S. K., Safe, S., Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007, 67, 2816-2823.
42. Willoughby, J. A. Sr., Sundar, S. N., Cheung, M., Tin, A. S. et al., Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. J. Biol. Chem. 2009, 284, 2203-2213.
43. Wang, L. G., Liu, X. M., Chiao, J. W., Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis 2006, 27, 2124-2132.
44. Cram, E. J., Liu, B. D., Bjeldanes, L. F., Firestone, G. L., Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol. Chem. 2001, 276, 22332-22340.
45. Hong, C., Kim, H. A., Firestone, G. L., Bjeldanes, L. F., 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1- mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002, 23, 1297-1305.
46. Davie, J. R., Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133, 2485S-2493.